Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes.
暂无分享,去创建一个
Pietro Cozzini | Glen E Kellogg | Donald J Abraham | Andrea Mozzarelli | Micaela Fornabaio | M. Fornabaio | D. Abraham | A. Mozzarelli | G. Kellogg | P. Cozzini
[1] J. Montgomery,et al. Protonation of methotrexate bound to the catalytic site of dihydrofolate reductase from lactobacillus casei , 1981 .
[2] B. Honig,et al. Calculation of electrostatic potentials in an enzyme active site , 1987, Nature.
[3] William L. Jorgensen,et al. Free energy calculations: a breakthrough for modeling organic chemistry in solution , 1989 .
[4] W G Laver,et al. Structures of aromatic inhibitors of influenza virus neuraminidase. , 1995, Biochemistry.
[5] P. Colman,et al. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor , 1992, Proteins.
[6] I. Miller,et al. Zanamivir: a review of clinical safety. , 1999, Drug safety.
[7] J. Varghese,et al. Development of neuraminidase inhibitors as anti‐influenza virus drugs , 1999 .
[8] J. C. Dyason,et al. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. , 1996, Journal of medicinal chemistry.
[9] Brian J Smith,et al. Structural studies of the resistance of influenza virus neuramindase to inhibitors. , 2002, Journal of medicinal chemistry.
[10] G. Air,et al. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding , 1995, Journal of virology.
[11] G. Flynn. Substituent Constants for Correlation Analysis in Chemistry and Biology. , 1980 .
[12] Peter R. Andrews,et al. Functional groups, drug-receptor interactions and drug design , 1986 .
[13] D. M. Ryan,et al. Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.
[14] G E Kellogg,et al. Computational methodology for estimating changes in free energies of biomolecular association upon mutation. The importance of bound water in dimer-tetramer assembly for beta 37 mutant hemoglobins. , 2000, Biochemistry.
[15] J. Mccammon,et al. On the evaluation and optimization of protein X‐ray structures for pKa calculations , 2003, Protein science : a publication of the Protein Society.
[16] Mark von Itzstein,et al. A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase , 1996, J. Comput. Aided Mol. Des..
[17] G E Kellogg,et al. Computationally accessible method for estimating free energy changes resulting from site‐specific mutations of biomolecules: Systematic model building and structural/hydropathic analysis of deoxy and oxy hemoglobins , 2001, Proteins.
[18] G. Klebe,et al. Approaches to the Description and Prediction of the Binding Affinity of Small-Molecule Ligands to Macromolecular Receptors , 2002 .
[19] M. Gilson,et al. Computing ionization states of proteins with a detailed charge model , 1996, J. Comput. Chem..
[20] J. Åqvist,et al. Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.
[21] A. Simas,et al. Importance of tautomers in the chemical behavior of tetracyclinesdagger. , 1999, Journal of pharmaceutical sciences.
[22] Themis Lazaridis,et al. Binding Affinity and Specificity from Computational Studies , 2002 .
[23] Julian Tirado-Rives,et al. Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations. , 2002, Journal of medicinal chemistry.
[24] G. Air,et al. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. , 1999, Journal of medicinal chemistry.
[25] T. K. Carne,et al. The origin of multiply sigmoid curves of pH-dependence. The partitioning of groups among titration pK values. , 1991, Biochemical Journal.
[26] Michael K. Gilson,et al. The determinants of pK(a)s in proteins , 1996 .
[27] M G Ford,et al. Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method. , 1999, Journal of medicinal chemistry.
[28] Glen E. Kellogg,et al. Hydrophobicity: is LogPo/w more than the sum of its parts? , 2000 .
[29] Peter A. Kollman,et al. FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .
[30] W G Laver,et al. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. , 1995, Journal of molecular biology.
[31] W G Laver,et al. Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. , 1997, Journal of molecular biology.
[32] P. Colman. Influenza virus neuraminidase: Structure, antibodies, and inhibitors , 1994, Protein science : a publication of the Protein Society.
[33] G E Kellogg,et al. Hydropathic analysis of the non-covalent interactions between molecular subunits of structurally characterized hemoglobins. , 1997, Journal of molecular biology.
[34] M. Gilson,et al. Prediction of pH-dependent properties of proteins. , 1994, Journal of molecular biology.
[35] Ajay,et al. Computational methods to predict binding free energy in ligand-receptor complexes. , 1995, Journal of medicinal chemistry.
[36] G. Kellogg,et al. Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues. , 2001, Bioorganic & medicinal chemistry letters.
[37] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[38] G. Air,et al. The neuraminidase of influenza virus , 1989, Proteins.
[39] G. Air,et al. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. , 1995, Journal of medicinal chemistry.
[40] P. Kollman,et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.
[41] J. Aqvist,et al. A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.
[42] G. Air,et al. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase , 1995, Proteins.
[43] E. Knapp,et al. Electrostatic models for computing protonation and redox equilibria in proteins , 1999, European Biophysics Journal.
[44] G. Ullmann,et al. Effects of pH on protein association: modification of the proton-linkage model and experimental verification of the modified model in the case of cytochrome c and plastocyanin. , 2001, Journal of the American Chemical Society.
[45] Anna Marabotti,et al. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water. , 2002, Journal of medicinal chemistry.
[46] M. Gilson,et al. The determinants of pKas in proteins. , 1996, Biochemistry.
[47] R. Wade,et al. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. , 2001, Journal of medicinal chemistry.
[48] J. N. Varghese,et al. Structure of the catalytic and antigenic sites in influenza virus neuraminidase , 1983, Nature.
[49] G. Air,et al. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. , 1987, Biochemistry.
[50] M. Gilson. Multiple‐site titration and molecular modeling: Two rapid methods for computing energies and forces for ionizable groups in proteins , 1993, Proteins.
[51] C. Silagy,et al. Effectiveness and role of zanamivir in the treatment of influenza infection. , 1999, Annals of medicine.
[52] A. Leo,et al. Extension of the fragment method to calculate amino acid zwitterion and side chain partition coefficients , 1987, Proteins.
[53] K. Goa,et al. Zanamivir , 1999, Drugs.
[54] P. Andrew Karplus,et al. Ordered water in macromolecular structure , 1994 .
[55] L Meijer,et al. Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition. , 2000, Anti-cancer drug design.
[56] N R Taylor,et al. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. , 1998, Journal of medicinal chemistry.
[57] Anna Marabotti,et al. Free energy of ligand binding to protein: evaluation of the contribution of water molecules by computational methods. , 2004, Current medicinal chemistry.
[58] R C Wade,et al. 'Flu' and structure-based drug design. , 1997, Structure.
[59] M. Karplus,et al. pKa's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. , 1990, Biochemistry.
[60] Brian J. Smith,et al. Analysis of inhibitor binding in influenza virus neuraminidase , 2001, Protein science : a publication of the Protein Society.
[61] G E Kellogg,et al. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. , 1991, Journal of medicinal chemistry.
[62] Glen Eugene Kellogg,et al. Very empirical treatment of solvation and entropy: a force field derived from Log Po/w , 2001, J. Comput. Aided Mol. Des..
[63] L. J. Bellamy,et al. Proton transfer in hydrogen bonded systems , 1960, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences.
[64] K. Sharp,et al. On the calculation of pKas in proteins , 1993, Proteins.
[65] J. Hanson,et al. Potent inhibition of pepsin and penicillopepsin by phosphorus-containing peptide analogues , 1990 .
[66] P. Kollman,et al. Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. , 2001, Annual review of biophysics and biomolecular structure.
[67] Peter C. Jurs,et al. Estimation of pKa for organic oxyacids using calculated atomic charges , 1993, J. Comput. Chem..
[68] M. Itzstein,et al. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position , 1993, Glycoconjugate Journal.
[69] B. Honig,et al. Classical electrostatics in biology and chemistry. , 1995, Science.
[70] Arieh Warshel,et al. Consistent Calculations of pKa's of Ionizable Residues in Proteins: Semi-microscopic and Microscopic Approaches , 1997 .
[71] S Cusack,et al. Influenza B virus neuraminidase can synthesize its own inhibitor. , 1993, Structure.
[72] Zongru Guo,et al. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors. , 2003, Bioorganic & medicinal chemistry.